• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿法磷酸酶-α可改善神经纤维瘤病 1 型小鼠模型的骨骼生长、矿化和强度。

Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.

机构信息

1] Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. [2] Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

1] Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. [2] Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, USA. [3] Department of Orthopaedic Surgery &Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee, USA. [4] Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.

出版信息

Nat Med. 2014 Aug;20(8):904-10. doi: 10.1038/nm.3583. Epub 2014 Jul 6.

DOI:10.1038/nm.3583
PMID:24997609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4126855/
Abstract

Individuals with neurofibromatosis type-1 (NF1) can manifest focal skeletal dysplasias that remain extremely difficult to treat. NF1 is caused by mutations in the NF1 gene, which encodes the RAS GTPase-activating protein neurofibromin. We report here that ablation of Nf1 in bone-forming cells leads to supraphysiologic accumulation of pyrophosphate (PPi), a strong inhibitor of hydroxyapatite formation, and that a chronic extracellular signal-regulated kinase (ERK)-dependent increase in expression of genes promoting PPi synthesis and extracellular transport, namely Enpp1 and Ank, causes this phenotype. Nf1 ablation also prevents bone morphogenic protein-2-induced osteoprogenitor differentiation and, consequently, expression of alkaline phosphatase and PPi breakdown, further contributing to PPi accumulation. The short stature and impaired bone mineralization and strength in mice lacking Nf1 in osteochondroprogenitors or osteoblasts can be corrected by asfotase-α enzyme therapy aimed at reducing PPi concentration. These results establish neurofibromin as an essential regulator of bone mineralization. They also suggest that altered PPi homeostasis contributes to the skeletal dysplasias associated with NF1 and that some of the NF1 skeletal conditions could be prevented pharmacologically.

摘要

患有神经纤维瘤病 1 型(NF1)的个体可能表现出局灶性骨骼发育不良,这些疾病仍然极难治疗。NF1 是由 NF1 基因的突变引起的,该基因编码 Ras GTP 酶激活蛋白神经纤维瘤。我们在这里报告,成骨细胞中 Nf1 的缺失导致焦磷酸盐(PPi)的超生理积累,PPi 是羟基磷灰石形成的强抑制剂,慢性细胞外信号调节激酶(ERK)依赖性增加促进 PPi 合成和细胞外转运的基因表达,即 Enpp1 和 Ank,导致这种表型。Nf1 缺失还可阻止骨形态发生蛋白-2 诱导的成骨前体细胞分化,从而导致碱性磷酸酶和 PPi 分解的表达减少,进一步导致 PPi 积累。缺乏成骨软骨细胞或成骨细胞中 Nf1 的小鼠的身材矮小以及骨矿物质化和强度受损,可以通过针对降低 PPi 浓度的 asfotase-α 酶疗法来纠正。这些结果确立了神经纤维瘤作为骨矿化的必需调节剂。它们还表明,改变的 PPi 动态平衡导致与 NF1 相关的骨骼发育不良,并且一些 NF1 骨骼状况可以通过药理学预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/695efe24b76d/nihms592135f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/b266b66dc36f/nihms592135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/cd45032799a5/nihms592135f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/daa708324fbd/nihms592135f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/483294c0aa41/nihms592135f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/bb61a4a3e19d/nihms592135f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/695efe24b76d/nihms592135f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/b266b66dc36f/nihms592135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/cd45032799a5/nihms592135f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/daa708324fbd/nihms592135f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/483294c0aa41/nihms592135f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/bb61a4a3e19d/nihms592135f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d82/4126855/695efe24b76d/nihms592135f6.jpg

相似文献

1
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.阿法磷酸酶-α可改善神经纤维瘤病 1 型小鼠模型的骨骼生长、矿化和强度。
Nat Med. 2014 Aug;20(8):904-10. doi: 10.1038/nm.3583. Epub 2014 Jul 6.
2
Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.骨软骨祖细胞中缺乏 Nf1 的小鼠表现出类似于神经纤维瘤病 I 型患者的骨骼发育不良。
Hum Mol Genet. 2011 Oct 15;20(20):3910-24. doi: 10.1093/hmg/ddr310. Epub 2011 Jul 14.
3
Strengthening bone in neurofibromatosis type 1.1型神经纤维瘤病中的骨质强化
Lab Anim (NY). 2014 Oct;43(10):338. doi: 10.1038/laban.639.
4
Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.联合MEK抑制和BMP2治疗可促进Nf1Osx -/-小鼠的成骨细胞分化和骨愈合。
J Bone Miner Res. 2015 Jan;30(1):55-63. doi: 10.1002/jbmr.2316.
5
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.由碱性磷酸酶2(akp2)、胞外核酸焦磷酸酶/磷酸二酯酶1(enpp1)和ank协同调节无机焦磷酸和骨桥蛋白:矿化障碍发病机制的整合模型
Am J Pathol. 2004 Apr;164(4):1199-209. doi: 10.1016/S0002-9440(10)63208-7.
6
JNK inhibitors increase osteogenesis in Nf1-deficient cells.JNK 抑制剂可增加 Nf1 缺陷细胞的成骨作用。
Bone. 2011 Dec;49(6):1311-6. doi: 10.1016/j.bone.2011.09.043. Epub 2011 Sep 22.
7
[Regulation of bone mineralization by enzymes].[酶对骨矿化的调节作用]
Clin Calcium. 2004 Jun;14(6):23-7.
8
Central role of pyrophosphate in acellular cementum formation.焦磷酸盐在无细胞牙骨质形成中的核心作用。
PLoS One. 2012;7(6):e38393. doi: 10.1371/journal.pone.0038393. Epub 2012 Jun 4.
9
A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).ANK 中的 Phe377del 突变导致一种颅缝早闭症(CMD)小鼠模型中的成骨细胞生成和破骨细胞生成受损。
Hum Mol Genet. 2011 Mar 1;20(5):948-61. doi: 10.1093/hmg/ddq541. Epub 2010 Dec 13.
10
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.神经纤维瘤病缺失小鼠胫骨骨不连中 Ras/MAPK 信号的过度激活是关键。
Hum Mol Genet. 2013 Dec 1;22(23):4818-28. doi: 10.1093/hmg/ddt333. Epub 2013 Jul 17.

引用本文的文献

1
Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.1型神经纤维瘤病相关骨折不愈合的分子基础
J Pediatr Soc North Am. 2025 May 23;12:100202. doi: 10.1016/j.jposna.2025.100202. eCollection 2025 Aug.
2
Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis.支持MEK抑制剂治疗神经纤维瘤病1型假关节的分子证据。
J Bone Joint Surg Am. 2025 May 21;107(10):1098-1106. doi: 10.2106/JBJS.24.01007. Epub 2025 Apr 1.
3
Spatial transcriptomics implicates impaired BMP signaling in NF1 fracture pseudarthrosis in murine and patient tissues.

本文引用的文献

1
The loss of activating transcription factor 4 (ATF4) reduces bone toughness and fracture toughness.激活转录因子4(ATF4)的缺失会降低骨韧性和断裂韧性。
Bone. 2014 May;62:1-9. doi: 10.1016/j.bone.2014.01.021. Epub 2014 Feb 7.
2
Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.多尺度、宏观孔隙率、微观结构和基质矿化的汇聚性缺陷影响1型神经纤维瘤病患者的长骨脆性。
PLoS One. 2014 Jan 21;9(1):e86115. doi: 10.1371/journal.pone.0086115. eCollection 2014.
3
Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.
空间转录组学表明,BMP 信号受损与 NF1 骨折假关节形成在鼠类和患者组织中有关。
JCI Insight. 2024 Jul 11;9(16):e176802. doi: 10.1172/jci.insight.176802.
4
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.评估 1 型神经纤维瘤病患者骨骼健康的潜在终点。
Clin Trials. 2024 Feb;21(1):29-39. doi: 10.1177/17407745231201338. Epub 2023 Sep 29.
5
Occipital bone defect caused by neurofibromatosis type I: A case report.I型神经纤维瘤病导致的枕骨缺损:病例报告。
Medicine (Baltimore). 2023 Jul 21;102(29):e34413. doi: 10.1097/MD.0000000000034413.
6
Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.神经纤维瘤病 1 型中躯体骨骼疾病的分子剖析。
J Bone Miner Res. 2023 Feb;38(2):288-299. doi: 10.1002/jbmr.4755. Epub 2022 Dec 13.
7
Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis.1型神经纤维瘤病相关营养不良性脊柱侧凸患者的基因型与临床干预
Front Pediatr. 2022 Aug 18;10:918136. doi: 10.3389/fped.2022.918136. eCollection 2022.
8
Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway.通过 ERK MAPK-mTOR 通路双向调节成骨细胞的发育。
Elife. 2022 Aug 17;11:e78069. doi: 10.7554/eLife.78069.
9
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.MEK 抑制剂治疗 1 型神经纤维瘤病表现:临床证据和共识。
Neuro Oncol. 2022 Nov 2;24(11):1845-1856. doi: 10.1093/neuonc/noac165.
10
Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques.利用具有临床转化潜力的技术鉴定神经纤维瘤病 1 型(NF1)小鼠模型中的骨基质损伤。
J Bone Miner Res. 2022 Aug;37(8):1603-1621. doi: 10.1002/jbmr.4633. Epub 2022 Jul 12.
激活素 A 通过改变细胞外基质 (ECM) 组成和损害基质小泡 (MV) 产生来抑制成骨细胞的矿化能力。
Mol Cell Proteomics. 2013 Oct;12(10):2890-900. doi: 10.1074/mcp.M112.024927. Epub 2013 Jun 17.
4
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.过度活跃的转化生长因子-β1 信号增强了神经纤维瘤病 1 型小鼠模型中的骨骼缺陷。
J Bone Miner Res. 2013 Dec;28(12):2476-89. doi: 10.1002/jbmr.1992.
5
The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.神经纤维瘤病蛋白的 ras-GTP 酶活性在软骨内骨形成过程中抑制 ERK 依赖性 FGFR 信号传导。
Hum Mol Genet. 2013 Aug 1;22(15):3048-62. doi: 10.1093/hmg/ddt162. Epub 2013 Apr 9.
6
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium.治疗1型神经纤维瘤病性胫骨假关节的方法:儿童肿瘤基金会1型神经纤维瘤病骨异常联盟的共识
J Pediatr Orthop. 2013 Apr-May;33(3):269-75. doi: 10.1097/BPO.0b013e31828121b8.
7
Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.转化生长因子 β 通过波形蛋白激活转录因子 4(ATF4)轴抑制成骨细胞分化。
J Biol Chem. 2012 Oct 19;287(43):35975-84. doi: 10.1074/jbc.M112.372458. Epub 2012 Sep 4.
8
Enzyme replacement prevents enamel defects in hypophosphatasia mice.酶替代治疗可预防低磷酸酯酶症小鼠的牙釉质缺陷。
J Bone Miner Res. 2012 Aug;27(8):1722-34. doi: 10.1002/jbmr.1619.
9
Enzyme-replacement therapy in life-threatening hypophosphatasia.危及生命的低磷酸酯酶症的酶替代疗法。
N Engl J Med. 2012 Mar 8;366(10):904-13. doi: 10.1056/NEJMoa1106173.
10
JNK inhibitors increase osteogenesis in Nf1-deficient cells.JNK 抑制剂可增加 Nf1 缺陷细胞的成骨作用。
Bone. 2011 Dec;49(6):1311-6. doi: 10.1016/j.bone.2011.09.043. Epub 2011 Sep 22.